NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $63.4M
This Quarter Return
+17.52%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
–
10 Year Return
–
AUM
$116M
AUM Growth
+$116M
Cap. Flow
+$10.2M
Cap. Flow %
8.79%
Top 10 Hldgs %
63.03%
Holding
49
New
5
Increased
5
Reduced
1
Closed
11

Top Buys

1
ZLAB icon
Zai Lab
ZLAB
$4.35M
2
SLNO icon
Soleno Therapeutics
SLNO
$3.23M
3
CLYM
Climb Bio, Inc. Common Stock
CLYM
$2.36M
4
REPL icon
Replimune Group
REPL
$909K
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
$866K

Top Sells

1
KALV icon
KalVista Pharmaceuticals
KALV
$750K
2
ATHA icon
Athira Pharma
ATHA
$477K
3
PACB icon
Pacific Biosciences
PACB
$376K
4
CABA icon
Cabaletta Bio
CABA
$353K
5
ROIV icon
Roivant Sciences
ROIV
$343K

Sector Composition

1 Healthcare 99.43%
2 Materials 0.57%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ILMN icon
1
Illumina
ILMN
$15.8B
$15.5M 13.39% 119,196 – –
HRMY icon
2
Harmony Biosciences
HRMY
$2.12B
$14.7M 12.7% 368,665 – –
GERN icon
3
Geron
GERN
$893M
$6.24M 5.37% 1,373,550 – –
MRUS icon
4
Merus
MRUS
$4.98B
$6M 5.17% 120,038 – –
ZLAB icon
5
Zai Lab
ZLAB
$3.68B
$5.67M 4.89% 235,000 +180,000 +327% +$4.35M
LBPH
6
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$5.35M 4.61% 160,570 +16,000 +11% +$533K
OCS icon
7
Oculis Holding
OCS
$844M
$5.35M 4.61% 436,378 – –
ONC
8
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$5.17M 4.45% 23,022 – –
INCY icon
9
Incyte
INCY
$16.5B
$4.89M 4.22% 74,022 – –
XENE icon
10
Xenon Pharmaceuticals
XENE
$2.98B
$4.2M 3.62% 106,680 – –
EXAI
11
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$4.2M 3.62% 859,892 – –
MIRM icon
12
Mirum Pharmaceuticals
MIRM
$3.71B
$4.14M 3.57% 106,100 – –
TRML icon
13
Tourmaline Bio
TRML
$601M
$3.77M 3.25% 146,800 – –
LAB icon
14
Standard BioTools
LAB
$481M
$3.63M 3.13% 1,883,179 – –
SLNO icon
15
Soleno Therapeutics
SLNO
$3.6B
$3.23M 2.78% +63,950 New +$3.23M
REPL icon
16
Replimune Group
REPL
$422M
$3.15M 2.72% 287,846 +82,907 +40% +$909K
RYTM icon
17
Rhythm Pharmaceuticals
RYTM
$6.85B
$2.57M 2.22% 49,120 – –
CLYM
18
Climb Bio, Inc. Common Stock
CLYM
$151M
$2.36M 2.03% +463,654 New +$2.36M
MDGL icon
19
Madrigal Pharmaceuticals
MDGL
$9.76B
$2.07M 1.78% 9,762 +4,080 +72% +$866K
ASND icon
20
Ascendis Pharma
ASND
$11.8B
$2.03M 1.75% 13,600 – –
KALV icon
21
KalVista Pharmaceuticals
KALV
$678M
$1.79M 1.54% 154,522 -64,755 -30% -$750K
EXEL icon
22
Exelixis
EXEL
$10.1B
$1.67M 1.44% 64,200 – –
ACAD icon
23
Acadia Pharmaceuticals
ACAD
$4.38B
$1.58M 1.36% 102,984 – –
RANI icon
24
Rani Therapeutics
RANI
$24.4M
$1.07M 0.92% 493,584 – –
TRDA icon
25
Entrada Therapeutics
TRDA
$208M
$784K 0.68% 49,082 – –
1
2